- Home
- MREO vs MVIS Comparison
MREO vs MVIS Comparison
Compare MREO & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | MVIS |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 45.0M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MREO | MVIS |
|---|---|---|
| Price | $0.34 | $1.20 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $1.96 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.67 | ★ 23.91 |
| EPS | ★ N/A | N/A |
| Revenue | $500,000.00 | ★ $664,000.00 |
| Revenue This Year | N/A | $1,017.55 |
| Revenue Next Year | N/A | $48.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $0.23 |
| 52 Week High | $2.37 | $4.90 |
Technical Indicators
Market Signals| Indicator | MREO | MVIS |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 32.81 |
| Support Level | $0.35 | $0.56 |
| Resistance Level | $0.35 | $1.89 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 47.31 | 0.93 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.